iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: http://pubmed.ncbi.nlm.nih.gov/38822442/
Update of the clinical guideline for hypertension diagnosis and treatment in Iran - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 1;30(1):13.
doi: 10.1186/s40885-024-00269-6.

Update of the clinical guideline for hypertension diagnosis and treatment in Iran

Fahimeh Bagherikholenjani  1 , Shahla Shahidi  1 , Alireza Khosravi  2   3 , Asieh Mansouri  2 , Vahid Ashoorion  4 , Nizal Sarrafzadegan  5   6 ; Guideline Updating Group (GUG); Steering Committee; Systematics Review Group (SRG); External Review Group (ERG)
Collaborators, Affiliations

Update of the clinical guideline for hypertension diagnosis and treatment in Iran

Fahimeh Bagherikholenjani et al. Clin Hypertens. .

Abstract

Background: This article introduces the updated version of the Iranian guideline for the diagnosis and treatment of hypertension in adults. The initial version of the national guideline was developed in 2011 and updated in 2014. Among the reasons necessitating the update of this guideline were the passage of time, the incompleteness of the scopes, the limitation of the target group, and more important is the request of the ministry of health in Iran.

Method: The members of the guideline updating group, after reviewing the original version and the new evidence, prepared 10 clinical questions regarding hypertension, and based on the evidence found from the latest scientific documents, provided recommendations or suggestions to answer these questions.

Result: According to the updated guideline, the threshold for office prehypertension diagnosis should be considered the systolic blood pressure (SBP) of 130-139 mmHg and/or the diastolic blood pressure (DBP) of 80-89 mmHg, and in adults under 75 years of age without comorbidities, the threshold for office hypertension diagnosis should be SBP ≥ 140 mmHg and or DBP ≥ 90 mmHg. The goal of treatment in adults who lack comorbidities and risk factors is SBP < 140 mmHg and DBP < 90 mmHg. The first-line treatment recommended in people with prehypertension is lifestyle modification, while for those with hypertension, pharmacotherapy along with lifestyle modification. The threshold to start drug therapy is determined at SBP ≥ 140 mmHg and or DBP ≥ 90 mmHg, and the first-line treatment is considered a drug or a combined pill of antihypertensive drugs, including ACEIs, ARBs, thiazide and thiazide-like agents, or CCBs. At the beginning of the pharmacotherapy, the Guideline Updating Group members suggested studying serum electrolytes, creatinine, lipid profile, fasting sugar, urinalysis, and an electrocardiogram. Regarding the visit intervals, monthly visits are suggested at the beginning of the treatment or in case of any change in the type or dosage of the drug until achieving the treatment goal, followed by every 3-to-6-month visits. Moreover, to reduce further complications, it was suggested that healthcare unit employees use telehealth strategies.

Conclusions: In this guideline, specific recommendations and suggestions have been presented for adults and subgroups like older people or those with cardiovascular disease, diabetes mellitus, chronic kidney disease, and COVID-19.

Keywords: Blood Pressure; Clinical practice Guideline; Diagnosis; Hypertension; Treatment; Updating.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Analytical framework of hypertension management in adults
Fig. 2
Fig. 2
The Flowchart of the Diagnosis and Treatment of Hypertension in Adults (Summary of Guideline Recommendations)
See this image and copyright information in PMC

Similar articles

  • The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
    Hackam DG, Khan NA, Hemmelgarn BR, Rabkin SW, Touyz RM, Campbell NR, Padwal R, Campbell TS, Lindsay MP, Hill MD, Quinn RR, Mahon JL, Herman RJ, Schiffrin EL, Ruzicka M, Larochelle P, Feldman RD, Lebel M, Poirier L, Arnold JM, Moe GW, Howlett JG, Trudeau L, Bacon SL, Petrella RJ, Milot A, Stone JA, Drouin D, Boulanger JM, Sharma M, Hamet P, Fodor G, Dresser GK, Carruthers SG, Pylypchuk G, Burgess ED, Burns KD, Vallée M, Prasad GV, Gilbert RE, Leiter LA, Jones C, Ogilvie RI, Woo V, McFarlane PA, Hegele RA, Tobe SW; Canadian Hypertension Education Program. Hackam DG, et al. Can J Cardiol. 2010 May;26(5):249-58. doi: 10.1016/s0828-282x(10)70379-2. Can J Cardiol. 2010. PMID: 20485689 Free PMC article. Review.
  • Interventions for deliberately altering blood pressure in acute stroke.
    Bath PM, Krishnan K. Bath PM, et al. Cochrane Database Syst Rev. 2014 Oct 28;2014(10):CD000039. doi: 10.1002/14651858.CD000039.pub3. Cochrane Database Syst Rev. 2014. PMID: 25353321 Free PMC article. Review.
  • The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy.
    Khan NA, Hemmelgarn B, Herman RJ, Bell CM, Mahon JL, Leiter LA, Rabkin SW, Hill MD, Padwal R, Touyz RM, Larochelle P, Feldman RD, Schiffrin EL, Campbell NR, Moe G, Prasad R, Arnold MO, Campbell TS, Milot A, Stone JA, Jones C, Ogilvie RI, Hamet P, Fodor G, Carruthers G, Burns KD, Ruzicka M, DeChamplain J, Pylypchuk G, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Vallée M, Howlett J, Bacon SL, Lindsay P, Gilbert RE, Lewanczuk RZ, Tobe S; Canadian Hypertension Education Program. Khan NA, et al. Can J Cardiol. 2009 May;25(5):287-98. doi: 10.1016/s0828-282x(09)70492-1. Can J Cardiol. 2009. PMID: 19417859 Free PMC article. Review.
  • The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
    Khan NA, Hemmelgarn B, Herman RJ, Rabkin SW, McAlister FA, Bell CM, Touyz RM, Padwal R, Leiter LA, Mahon JL, Hill MD, Larochelle P, Feldman RD, Schiffrin EL, Campbell NR, Arnold MO, Moe G, Campbell TS, Milot A, Stone JA, Jones C, Ogilvie RI, Hamet P, Fodor G, Carruthers G, Burns KD, Ruzicka M, dechamplain J, Pylypchuk G, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Vallée M, Howlett J, Katzmarzyk P, Tobe S, Lewanczuk RZ; Canadian Hypertension Education Program. Khan NA, et al. Can J Cardiol. 2008 Jun;24(6):465-75. doi: 10.1016/s0828-282x(08)70620-2. Can J Cardiol. 2008. PMID: 18548143 Free PMC article. Review.
  • Screening for Hypertension in Children and Adolescents: Systematic Review for the U.S. Preventive Services Task Force [Internet].
    Gartlehner G, Vander Schaaf EB, Orr C, Kennedy SM, Clark R, Viswanathan M. Gartlehner G, et al. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Nov. Report No.: 20-05261-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Nov. Report No.: 20-05261-EF-1. PMID: 33284560 Free Books & Documents. Review.
See all similar articles

References

    1. Bastian H, Glasziou P, Chalmers I. Seventy-five trials and eleven systematic reviews a day: how will we ever keep up? PLoS Med. 2010;7(9):e1000326. doi: 10.1371/journal.pmed.1000326. - DOI - PMC - PubMed
    1. García LM, Pardo-Hernández H, Sanabria AJ, Alonso-Coello P, Penman K, McFarlane E, et al. Guideline on terminology and definitions of updating clinical guidelines: the updating glossary. J Clin Epidemiol. 2018;95:28–33. doi: 10.1016/j.jclinepi.2017.11.023. - DOI - PubMed
    1. Steinberg E, Greenfield S, Wolman DM, Mancher M, Graham R. Clinical practice guidelines we can trust. Washington, D.C: National Academies Press; 2011. - PubMed
    1. Alderson LJ, Alderson P, Tan T. Median life span of a cohort of National Institute for Health and Care Excellence clinical guidelines was about 60 months. J Clin Epidemiol. 2014;67(1):52–55. doi: 10.1016/j.jclinepi.2013.07.012. - DOI - PubMed
    1. Martínez García L, Arévalo-Rodríguez I, Solà I, Haynes RB, Vandvik PO, Alonso-Coello P, et al. Strategies for monitoring and updating clinical practice guidelines: a systematic review. Implement Sci. 2012;7:1–10. doi: 10.1186/1748-5908-7-109. - DOI - PMC - PubMed

LinkOut - more resources